BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22507529)

  • 1. Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro.
    Dil N; Banerjee AG
    Head Neck Oncol; 2012 Jun; 4():11. PubMed ID: 22507529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.
    Dil N; Banerjee AG
    Head Neck Oncol; 2011 Sep; 3():44. PubMed ID: 21958730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
    Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
    Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
    Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
    Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
    Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
    J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and phenotypic expression of decorin as modulator of angiogenesis in human potentially malignant oral lesions and oral squamous cell carcinomas.
    Nayak S; Goel MM; Bhatia V; Chandra S; Makker A; Kumar S; Agrawal SP; Mehrotra D; Rath SK
    Indian J Pathol Microbiol; 2013; 56(3):204-10. PubMed ID: 24152495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis-related prognosis in patients with oral squamous cell carcinoma-role of the VEGF +936 C/T polymorphism.
    Kämmerer PW; Al-Nawas B; Kalkan S; Liese J; Fruth K; Frerich B; Brieger J
    J Oral Pathol Med; 2015 Jul; 44(6):429-36. PubMed ID: 25213013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
    Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
    Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.
    Shellenberger TD; Mazumdar A; Henderson Y; Briggs K; Wang M; Chattopadhyay C; Jayakumar A; Frederick M; Clayman GL
    Cancer Res; 2005 Dec; 65(24):11501-9. PubMed ID: 16357159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
    Agnihotri NS; Astekar M
    J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
    Liu XQ; Yao Y; Mu JW; Yang FY
    Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma.
    Oh SH; Kim WY; Lee OH; Kang JH; Woo JK; Kim JH; Glisson B; Lee HY
    Cancer Sci; 2012 Jul; 103(7):1259-66. PubMed ID: 22494072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma.
    Babkair H; Yamazaki M; Uddin MS; Maruyama S; Abé T; Essa A; Sumita Y; Ahsan MS; Swelam W; Cheng J; Saku T
    Hum Pathol; 2016 Nov; 57():51-60. PubMed ID: 27436828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
    Houri A; Mukudai Y; Abe Y; Watanabe M; Nara M; Miyamoto S; Kurihara M; Shimane T; Shirota T
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.